`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`
`
`91 1 99863
`
`Defendant
`
`Xellia Pharmaceuticals ApS
`DANIELLE I MA'|'|'ESS|CH
`MERCHANT & GOULD PC
`PO BOX 291080 S 8TH STREET, SUITE 3200
`MINNEAPOLIS, MN 55402
`UNITED STATES
`
`dmattessich@merchantgou|d.com, dockmp|s@merchantgou|d.com
`
`Other Motions/Papers
`Danielle I. Mattessich
`
`
`
`dockmp|s@merchantgou|d.com, dmattessich@merchantgou|d.com
`ldaniellemattessichl
`
`04/04/2013
`
`XELLIA Motion & Stip Amemdment.pdf (5 pages )(135985 bytes)
`
`Trademark Trial and Appeal Board Electronic Filing System. http://estta.uspto.gov
`ESTTA530617
`ESTTA Tracking number:
`04/04/2013
`
`Filing date:
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`91199863
`Defendant
`Xellia Pharmaceuticals ApS
`DANIELLE I MATTESSICH
`MERCHANT & GOULD PC
`PO BOX 291080 S 8TH STREET, SUITE 3200
`MINNEAPOLIS, MN 55402
`UNITED STATES
`dmattessich@merchantgould.com, dockmpls@merchantgould.com
`Other Motions/Papers
`Danielle I. Mattessich
`dockmpls@merchantgould.com, dmattessich@merchantgould.com
`/daniellemattessich/
`04/04/2013
`XELLIA Motion & Stip Amemdment.pdf ( 5 pages )(135985 bytes )
`
`Proceeding
`Party
`
`Correspondence
`Address
`
`Submission
`Filer's Name
`Filer's e-mail
`Signature
`Date
`Attachments
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`M&G: 60361.0005USTA
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`Opposition No. 91199863
`
`
`
`
`APPLICANT’S MOTION TO RESUME PROCEEDINGS
`FOR CONSIDERATION OF STIPULATED AMENDMENT
`OF U.S. APP. NO. 79/075436 (XELLIA)
`
`Applicant hereby moves this Board for an order to resume proceedings.
`
`
`
`Pursuant to TBMP §510.03, each party has the right to request resumption of the
`
`proceedings at any time during a suspension period.
`
`
`
`Upon consideration of Applicant’s Motion for Suspension for Settlement With
`
`Consent filed on March 15, 2013, the Board ordered this case be suspended through May
`
`14, 2013. The parties have now resolved the issues regarding this opposition and as such,
`
`Applicant respectfully requests the Board to resume proceedings for consideration of the
`
`accompanying Stipulated Amendment of Application.
`
`
`
`
`
`
`
`
`
`
`
`
`In the matter of U.S. Application No. 79/075436
`Mark: XELLIA
`
`
`
`
`
`
`
`MSP Singapore Company, LLC,
`
`
`
`
`
`
`
`
`
`
`Opposer,
`
`
`
`
`
`
`
`
`vs.
`
`
`
`
`
`
`
`
`
`Xellia Pharmaceuticals ApS,
`
`
`
`
`
`
`
`
`
`
`
`Applicant.
`
`
`
`
`
`
`
`
`
`Opposition No. 91199863=
`
`It is believed that no fee is required for filing this paper. In the event that any fee
`
`is required, the Commissioner of Trademarks is authorized to charge any fees in
`
`connection herewith to Deposit Account No. 13-2725.
`
`Respectfully submitted,
`
`XELLIA PHARMACEUTICALS APS
`
`
`
`By its attorneys,
`
`
`
`___________________________________
`MERCHANT & GOULD P.C.
`P.O. Box 2910
`Minneapolis, MN 55402
`Telephone: (612) 332-5300
`Facsimile: (612) 332-9081
`dmattessich@merchantgould.com
`dockmpls@merchantgould.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`April 4, 2013
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`_________________________
`Date
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`=
`
`O
`
`
`
`
`
`Opposition No. 91199863=
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that a true and correct copy of the foregoing APPLICANT’S
`
`
`
`
`
`MOTION TO RESUME PROCEEDINGS FOR CONSIDERATION OF STIPULATED
`
`AMENDMENT OF U.S. APP. NO. 79/075436 (XELLIA) and STIPULATED
`
`AMENDMENT was served upon the following attorney of record for Applicant by First
`
`Class Mail, postage pre-paid, this 4th day of April, 2013:
`
`Christopher Bolinger
`Merck & Co., Inc.
`126 E. Lincoln Avenue
`Rahway, New Jersey 07065
`
`
`
`
`
`
`
`April 4, 2013
`
`
`
`
`
`_________________________
`Date
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`=
`
`
`
`___________________________________
`MERCHANT & GOULD P.C.
`P.O. Box 2910
`Minneapolis, MN 55402
`Telephone: (612) 332-5300
`Facsimile: (612) 332-9081
`dmattessich@merchantgould.com
`dockmpls@merchantgould.com
`
`
`
`
`
`
`
`
`P
`
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`
`
`)
`
`) )
`
`) Opposition No. 91199863
`) App. No. 79/075436
`) Mark: XELLIA
`)
`
`) )
`
`MSP Singapore Company, LLC,
`
`Opposer,
`
`V_
`
`Xellia Pharmaceuticals ApS,
`
`
`
`Applicant. 5
`
`United States Patent and Trademark Office
`Trademark Trial and Appeal Board
`PO. Box 1451
`
`Alexandria, VA 22313-1451
`
`STIPULATED AMENDMENT OF APPLICATION
`
`Applicant, with the consent of Opposer, hereby respectfully requests that the Board
`
`amend Application Serial No. 79/075436 (XELLIA) to identify the goods in classes 5 and 10 as
`
`follows (NOTE: The proposed changes have been underlined for the ease of identification):
`
`Pharmaceutical and veterinary preparations, namely, anti-infective, anti-viral, antibiotic,
`anti—funga1 and anti-inflammatory preparations in bulk and finished dosage form for
`medical and veterinary purposes, not for use as finished diagnostic preparations an_d
`specifically excluding finished pharmaceutical preparations in the form of tablets as well
`as cardiovascular finished pharmaceutical preparation ; sanitary preparations for medical
`purposes, not for use as finished diagnostic preparations; dietetic substances adapted for
`medical use, namely, foods; disinfectants for sanitary and medical purposes; preparations
`for destroying vermin; fungicides; herbicides (international class 5).
`
`Medical apparatus for introducing pharmaceutical preparations into the human body,
`specifically excluding cardiovascular preparations (international class 10).
`
`The description of goods and services in classes 1 and 42 remain unchanged.
`
`The parties believe that acceptance of the identification of goods in classes 5 and 10 as
`
`set forth above resolves the outstanding issues between the parties and will ultimately result. in
`
`the withdrawal of this opposition by Opposer. The parties also believe that the proposed
`
`
`
`amendment is within the scope of the identification of goods set forth in the Notice of
`
`Publication and thus, is acceptable.
`
`Respectfully submitted,
`
`MSP Singapore Company, LLC
`
`Xellia Pharmaceuticals ApS
`
`Q /7/azamab By:
`
`A
`
`1“ A 1'
`
`M°"°k & C0 19°
`One Merck Drive
`W1l11t;1$ous:Sta£1§n, NJ 08889
`Te 7
`'59 '09
`
`Merchant & Gould P.C.
`P 0 BOX 2910
`Minneapolis, MN 55402
`Tel (612) 336-4725
`
`christopher.bo1inger@merck.com
`Dated‘ Mmh 2”?» 2013
`
`‘
`
`dm
`
`'
`
`.
`
`docitfigiégggglgnigfiffid Soigm
`Dated° March 21 2013
`
`h
`
`ul
`
`.